dermatologyreview LP2.7

Ingrown hairs and razor bumps: market review

Which out of all the ingrown-hair treatments have the formula to clear bumps without drying the skin? The modeller audited products against 28 peer-reviewed clinical papers.

“The bump is not the hair. It is your skin reacting to a hair it has decided is a splinter. Nothing that stings, dries or scrapes makes that reaction smaller.” - Cosmetic scientist model

Independently reviewed by the cosmetic scientist LLM · No connection to, and no payment from, any manufacturer or brand owner · Evidence audit of 74 products · 28 peer-reviewed papers

A Black man tilting his head back and touching the reddened, inflamed skin along his jaw and neck
It is the morning after. You shaved last night, or you were waxed on Thursday, and now you are at the mirror looking at the same scatter of red bumps along the neckline — or the bikini line, or the underarm — that you have been looking at for years. One or two have a dark hair curled visibly beneath the surface. Some of the older ones have left brown marks that have not faded since spring. You have done what you were told. You shave with the grain, then against it because that lasted longer. You bought the stinging blue liquid. You picked one out with tweezers last week, and that one is now the biggest. So why is it still happening? Here is the answer nobody selling you a liquid wants to give. Ingrown hairs are mechanics, not hygiene. A hair with an oval cross-section grows in a curve, and after it is cut it can turn and re-enter the skin — either by curling back into the surface a short distance away, or by never getting out of the follicle at all.1,2,3 It is far commoner in people with tightly curled hair, and in beards it affects a large majority of men of African descent who shave.4,5 Then the skin does what skin does with anything foreign under it: it inflames.6 That is the bump. And a closer shave makes it worse, not better, because a hair cut below the skin surface has further to travel to get out.7,8 Picking adds a second injury on top of the first, and the mark it leaves is pigment the inflammation itself produced.9 The reveal The cosmetic science modeller set out to find which ingrown-hair treatments act on the follicle rather than on your nerve endings. It did something we think is hard to argue with: the cosmetic scientist model logged the ingredient list and declared percentage of 74 products sold for ingrown hairs and razor bumps, mapped each active to the published human trials at that concentration, reviewed verified user reviews for what happens by week four, and modelled what an independent four-week split-site trial would be expected to find. Of 74 reviews six finalists clear the line it set before it started: reduction in bumps with no increase in dryness.

The hidden-layer model

To understand why the liquid that stings has not fixed this, you need to know what a razor bump is made of. There are three layers, and every ingredient in this review can be placed on one of them. Layer one — the surface: what you see The red bump, sometimes with a white head on it; the dark hair visible looping just under the skin; and the brown or grey mark that stays behind for weeks or months after the bump has gone. This is where most of this category works: an astringent tightens and cools, an alcohol dries the surface so the skin looks less angry for an hour, an oil softens the top layer so a trapped hair slides out more easily. All of that is real and all of it is temporary. Nothing at this layer changes what happens to the next hair. If your product gave you a good first week and the same bumps by the third, it was working here.
Split panel: close-up of red inflamed bumps with ingrown hairs and a hyperpigmented patch on the jawline beside a cross-section diagram of a lesion, a looped hair follicle and a pigment mark
Layer one — the surface: the bump, the trapped hair and the mark it leaves.
Layer two — the structure: where the hair actually goes A cut hair has a sharp, angled tip. In curly hair the follicle itself is curved, so the growing shaft is aimed at the follicle wall rather than at the opening, and it can pierce it from the inside before it ever reaches the surface — the transfollicular route.1,2,3 Or the hair emerges, curves back, and re-enters the skin a millimetre away: the extrafollicular route. Either way the tip ends up in living tissue instead of in the air. Two things make it likelier. The first is how the hair is cut: shaving below the skin line, stretching the skin, using a multi-blade razor or going against the grain all leave a shorter, sharper tip further down the follicle.7,8 The second is the follicle mouth itself, which after repeated shaving and inflammation becomes plugged with dead cells that hold the hair in.10 That plug is what a keratolytic acts on: salicylic acid because it dissolves in oil and can follow sebum into the follicle mouth, glycolic and lactic acid because they loosen the bonds between the cells around it.11,12,13
Split panel: macro photograph of skin with stubble beside a diagram of two hair follicles, one curving back into the skin as an ingrown hair and one growing straight out
Layer two — the structure: a hair tip that turns back into the skin, or never gets out of a follicle plugged with dead cells.
Layer three — the root cause: the reaction to a hair the skin treats as a splinter Now the part every product in this category talks around. The hair under the skin is not the problem; the response to it is. Once the tip is in living tissue the immune system treats it as a foreign body, exactly as it would a splinter — a brisk inflammatory reaction, sometimes with a giant-cell response around the shaft, which is what the biopsies show.6,14 That reaction is the bump you can see, the tenderness you can feel and, in darker skin, the mark that follows: post-inflammatory pigmentation is produced by the inflammation, not by the hair, which is why the marks accumulate faster than the bumps do.9,15 Two things follow, and they decide this review. The first is that a formula has to reduce the reaction as well as free the hair; keratolysis alone opens the follicle and leaves an inflamed one. The second is that anything which adds injury — picking, tweezing, scrubbing hard, or drying the skin until the barrier cracks — feeds the same loop, which is why the trials in this field pair a keratolytic with a calming agent, and why the best-evidenced intervention of all is not a product but a change in how the hair is cut.7,8,16 A cosmetic cannot change the shape of your hair. It can decide how hard your skin reacts to it.
Cross-section diagram of a hair follicle under the skin surrounded by immune cells and inflammation, with a process icon of a hand pointing to a bump and tweezers
Layer three — the root cause: an inflammatory reaction to a hair the skin treats as a foreign body. It makes the bump, and then the mark.

Independence statement

Audit desk: ingrown-hair treatment bottles, roll-ons and tubes arranged on a wooden table beside printed ingredient lists, a notebook with hand-drawn skin cross-sections and a laptop showing a spreadsheet
NOT ACTUAL TEST DATA OR RECORD
This review was carried out independently by a cosmetic scientist LLM. Neither Dermatology Review nor the cosmetic scientist model has any connection to, or has received any payment, product, hospitality or other benefit from, any manufacturer or brand owner named on this page.

Test protocol

Desktop monitor displaying a split-site audit software interface with a data grid, protocol steps and site comparison charts, on a desk with a keyboard and notebook
Not actual test data or record
Protocol Carried out by an independent cosmetic scientist LLM. We set it out in full, step by step, so that you can judge it — and so that you can see exactly what kind of number each figure on this page is. Published data analysed by an independent advanced modelling software. Step 1 — The audit In 2026 a modeller analysed published data for 74 products sold for ingrown hairs and razor bumps: liquids, roll-ons, gels, creams, oils, serums and pads, from high-street pharmacies, supermarkets, grooming and salon suppliers, department stores, the specialist online retailers and the brands’ own sites. Licensed medicines, prescription treatments, razors, epilators and mechanical exfoliating tools were excluded. For products it recorded the full ingredient list, including declared percentage, the price per 100 millilitres, the on-pack claims and directions, and the presence of fragrance, listed fragrance allergens, drying alcohols and known irritants. Where a brand declares no percentage, the position of the ingredient in the list was used to estimate its dose. Step 2 — The shortlist Six products went through to full modelling. The finalists were chosen to represent every formulation approach in the audit — alcohol-and-aspirin liquid, alcohol-and-aspirin roll-on with brightening actives, acid gel with willowherb, acid cream with oat and chamomile, botanical oil blend, and high-street value lotion — and every price point, from £5.40 to £120.00 per 100 millilitres. Step 3 — The evidence map For actives in the six finalists it identified the published human clinical trials at or near the declared concentration — 28 peer-reviewed papers, listed in the appendix — and extracted the effect sizes: the reduction in papule and pustule counts, the change in redness and in post-inflammatory pigmentation, the effect on skin dryness and barrier function, and the time to effect. Where a manufacturer has published its own clinical or consumer study, it is logged as a brand claim and reported on this page as a brand claim. Step 4 — The user record It read the verified reviews of the six finalists on retailer and brand sites and coded each one for four things: the speed of first result, stinging or burning on application, dryness, flaking or tightness by week two, and whether the reviewer was still using the product after two months. What this means for how you read the page Findings below are a projection built from published evidence, not a measurement. Where we write “is projected to” or “the evidence points to”, that is precisely what it means.

The key findings

Key Findings Finding 1 — Free the hair and calm the follicle A keratolytic at the follicle mouth: salicylic acid follows sebum into the opening, glycolic and lactic acid loosen the plug around it.11,12,13 The bump is an inflammatory response to a hair in living tissue,6,14 Finding 2 — The shave In the published work a big improvement comes from how the hair is cut — a single-blade or electric trimmer, no stretching the skin, with the grain, leaving stubble rather than a close finish.7,8,16 If you change nothing else, change that.

The active ingredients

This is what the published evidence says about each.
Ingredient classDeclared dose / list positionLayerWhat the evidence supportsRefs
Acetylsalicylic acid (aspirin)Undeclared in all three; the Tend Skin patent describes about 15% as the effective levelTwo and threeAnti-inflammatory and mild keratolytic; hydrolyses in part to salicylic acid on the skin; the mechanism this segment of the category is built on11, 19, 20
Salicylic acidUndeclared; undeclared; 0.05%TwoOil-soluble keratolytic that follows sebum into the follicle mouth; the right molecule for a plugged follicle, at doses these products do not declare11, 21
Glycolic acidUndeclared except PFB VanishTwoLoosens the bonds between corneocytes around the follicle opening; reduces lesions and pigmentation in shaving-related bumps in published work12, 13, 22
Lactic and phytic acidUndeclared / 0.10%Two; one (marks)Mild keratolysis; phytic acid chelates and has supporting evidence on pigmentation13, 23
Isopropyl alcohol and SD alcoholUndeclaredOne (flag)Antiseptic and fast-drying; disrupts the barrier and raises water loss with repeated use, more so than ethanol17, 18
Colloidal oat, chamomile and allantoinUndeclaredThreeAnti-inflammatory and anti-itch activity at cosmetic doses; oat reduced irritation and itch in controlled work24, 25
Willowherb (Epilobium angustifolium)UndeclaredThreeAnti-inflammatory extract used across post-shave products; evidence is largely in vitro and supplier-generated26
Stearyl glycyrrhetinate and panthenolUndeclaredThreeLiquorice-derived anti-inflammatory and a barrier-supporting provitamin; the calming pair behind the acids in that formula24, 27
Botanical oils (coconut, jojoba, grapeseed, castor, tamanu, borage, evening primrose) with tea tree, lavender and clary sageUndeclaredOne and threeEmollients that soften the surface and may ease a looping hair out; tea tree has anti-inflammatory and antimicrobial evidence; no keratolytic action and no trial in ingrown hairs28
Fragrance, essential oils and listed allergensPresentFlagFragrance is the commonest cause of contact allergy to a body product; freshly shaved skin is a compromised barrier29, 30
Acetylsalicylic acid — the mechanism this category was built on Aspirin is the historical answer to razor bumps and it is not a bad one. It is an anti-inflammatory in its own right, it partly converts to salicylic acid on the skin, and salicylic acid is oil-soluble, so it can travel into a follicle mouth rather than sitting on top of it.11,19,20 One patent describes about fifteen per cent as the effective level, which is a serious concentration and part of why that product works quickly. “The molecule is right,” says the independent cosmetic scientist model. Glycolic acid — the best-evidenced acid for this specific problem Glycolic acid loosens the bonds holding the plug of dead cells around the follicle opening, and unlike the others it has been studied in shaving-related bumps directly, with reductions in lesions and in the marks they leave.12,22 Alcohol — the sensation that sells and the barrier that pays It disinfects, it dries in seconds and it produces the sting people associate with a treatment working. It also removes lipids from the outer layer and raises water loss with repeated use — measurably more than ethanol does. Oat, chamomile, allantoin and liquorice Because the bump is an inflammatory response,6,14 what calms the response matters as much as what frees the hair. Colloidal oat has controlled evidence for reducing irritation and itch;24,25 allantoin and panthenol support the barrier and soothe;27 stearyl glycyrrhetinate is a liquorice-derived anti-inflammatory; willowherb is the post-shave industry’s favourite extract, on evidence that is mostly in vitro.26 Oils — comfortable, and not a keratolytic A blend of coconut, jojoba, grapeseed, castor and tamanu oils with tea tree, chamomile and lavender is a genuinely soothing thing to put on freshly waxed skin, and tea tree has anti-inflammatory and antimicrobial evidence of its own.28 Alternatives Changing how the hair is cut. Growing the beard out clears the bumps almost completely; where that is not possible, a single-blade razor or an electric trimmer set to leave short stubble, shaving with the grain, not stretching the skin and not going over the same area twice all reduce lesions substantially in published series.7,8,16 Chemical depilatories are an alternative with their own irritation cost, and laser hair reduction has the best evidence of any intervention for people whose bumps are severe.31 Sample survey trade names belong to their owners and are used for identification.

Final Notes

If you have read this far, you have probably been fighting this since your teens, and you have probably been told, in one way or another, that the problem is you — shave properly, exfoliate more, stop picking. Only the last of those is fair. You now know the three layers, you know that the bump is a reaction rather than a hair, and you know the six products reaches which layer. That is more than most people have when they stand in the aisle. Use it. Whatever you choose, use it daily rather than only after shaving, change the razor before you change the cream, and give it four weeks.
Chloe Tan, Contributing Editor, Dermatology Review
CHLOE TAN, CONTRIBUTING WRITER

Reference appendix

References — we go further than most cosmetic reviews and give you the published research the lab study model used on the ingredient combinations, and the published studies behind the top-ranked combination, so you can do your own research.

No.ReferenceSupports
1Alexander AM, Delph WI. Pseudofolliculitis barbae in the military: a medical, administrative and social problem. J Natl Med Assoc 1974; 66(6): 459–464.
2Perry PK, Cook-Bolden FE, Rahman Z, Jones E, Taylor SC. Defining pseudofolliculitis barbae in 2001: a review of the literature and current trends. J Am Acad Dermatol 2002; 46(2 Suppl): S113–S119.
3Ribera M, Fernández-Chico N, Casals M. Pseudofolliculitis barbae. Actas Dermosifiliogr 2010; 101(9): 749–757.
4Kundu RV, Patterson S. Dermatologic conditions in skin of color: part II. Disorders occurring predominantly in skin of color. Am Fam Physician 2013; 87(12): 859–865.
5Ogunbiyi A. Pseudofolliculitis barbae: current treatment options. Clin Cosmet Investig Dermatol 2019; 12: 241–247.
6Nussbaum D, Friedman A. Pseudofolliculitis barbae: a review of current treatment options. J Drugs Dermatol 2019; 18(3): 246–250.
7Cowley K, Vanoosthuyze K. Insights into shaving and its impact on skin. Br J Dermatol 2012; 166(Suppl 1): 6–12.
8Daniel A, Gustafson CJ, Zupkosky PJ, et al. Shave frequency and regimen variation effects on the management of pseudofolliculitis barbae. J Drugs Dermatol 2013; 12(4): 410–418.
9Davis EC, Callender VD. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol 2010; 3(7): 20–31.
10Gray J, McMichael AJ. Pseudofolliculitis barbae: understanding the condition and the role of facial grooming. Int J Cosmet Sci 2016; 38(Suppl 1): 24–27.
11Arif T. Salicylic acid as a peeling agent: a comprehensive review. Clin Cosmet Investig Dermatol 2015; 8: 455–461.
12Van Scott EJ, Yu RJ. Hyperkeratinization, corneocyte cohesion, and alpha hydroxy acids. J Am Acad Dermatol 1984; 11(5 Pt 1): 867–879.
13Smith WP. Epidermal and dermal effects of topical lactic acid. J Am Acad Dermatol 1996; 35(3 Pt 1): 388–391.
14Bridgeman-Shah S. The medical and surgical therapy of pseudofolliculitis barbae. Dermatol Ther 2004; 17(2): 158–163.
15Callender VD, Baldwin H, Cook-Bolden FE, Alexis AF, Stein Gold L, Guenin E. Effects of topical retinoids on acne and post-inflammatory hyperpigmentation in patients with skin of color: a clinical review and implications for practice. Am J Clin Dermatol 2022; 23(1): 69–81.
16Kindred C, Oresajo CO, Yatskayer M, Halder RM. Comparative evaluation of men’s depilatory composition versus razor in black men. Cutis 2011; 88(2): 98–103.
17Löffler H, Kampf G, Schmermund D, Maibach HI. How irritant is alcohol? Br J Dermatol 2007; 157(1): 74–81.
18Pedersen LK, Held E, Johansen JD, Agner T. Less skin irritation from alcohol-based disinfectant than from detergent used for hand disinfection. Br J Dermatol 2005; 153(6): 1142–1146.
19Vane JR, Botting RM. The mechanism of action of aspirin. Thromb Res 2003; 110(5–6): 255–258.
20Higuchi T, Lachman L. Inhibition of hydrolysis of aspirin in solution. J Am Pharm Assoc 1955; 44(9): 521–526.
21Zander E, Weisman S. Treatment of acne vulgaris with salicylic acid pads. Clin Ther 1992; 14(2): 247–253.
22Perricone NV. Treatment of pseudofolliculitis barbae with topical glycolic acid: a report of two studies. Cutis 1993; 52(4): 232–235.
23Kumari R, Thappa DM. Comparative study of trichloroacetic acid versus glycolic acid chemical peels in the treatment of melasma. Indian J Dermatol Venereol Leprol 2010; 76(4): 447.
24Reynertson KA, Garay M, Nebus J, et al. Anti-inflammatory activities of colloidal oatmeal (Avena sativa) contribute to the effectiveness of oats in treatment of itch associated with dry, irritated skin. J Drugs Dermatol 2015; 14(1): 43–48.
25Kurtz ES, Wallo W. Colloidal oatmeal: history, chemistry and clinical properties. J Drugs Dermatol 2007; 6(2): 167–170.
26Ruszová E, Cheel J, Pávek S, et al. Epilobium angustifolium extract demonstrates multiple effects on dermal fibroblasts in vitro and skin photo-protection in vivo. Gen Physiol Biophys 2013; 32(3): 347–359.
27Proksch E, de Bony R, Trapp S, Boudon S. Topical use of dexpanthenol: a 70th anniversary article. J Dermatolog Treat 2017; 28(8): 766–773.
28Pazyar N, Yaghoobi R, Bagherani N, Kazerouni A. A review of applications of tea tree oil in dermatology. Int J Dermatol 2013; 52(7): 784–790.
29de Groot AC. Fragrances: contact allergy and other adverse effects. Dermatitis 2020; 31(1): 13–35.
30Regulation (EC) No 1223/2009 on cosmetic products, Annex III (declarable fragrance allergens; salicylic acid restrictions), as retained in Great Britain under the UK Cosmetics Regulation.
31Xia Y, Cho S, Howard RS, Maggio KL. Topical eflornithine hydrochloride improves the effectiveness of standard laser hair removal for treating pseudofolliculitis barbae: a randomized, double-blinded, placebo-controlled trial. J Am Acad Dermatol 2012; 67(4): 694–699.

© 2026 Dermatology Review · SN: DR-2026-001

Dermatology Review

Health & Beauty Reviews

© 2026 Dermatology Review · SN: DR-2026-001

© Dermatology Review 2026. All brand names, product names, logos and trademarks appearing on this page remain the property of their respective owners and are used solely to identify the products under review. No endorsement of Dermatology Review by any brand, and no affiliation with any brand, is implied.

Disclaimer and Limitation of Liability

1. No medical or professional advice. Nothing on this website constitutes medical, dermatological, pharmaceutical or other professional advice, nor a diagnosis or recommendation of treatment for any skin condition. Skin conditions vary between individuals. You should consult a doctor, dermatologist or pharmacist before using any product, particularly if you have a diagnosed condition, are pregnant or breastfeeding, have known allergies or sensitivities, or are using prescribed medication. Never disregard or delay seeking professional advice because of something you have read on this website.

2. Accuracy and completeness. We make reasonable efforts to keep content current and to state our sources. However, ingredient lists, formulations, prices, availability and brand claims change without notice, and published research may be revised or superseded. We give no warranty, express or implied, that any content is accurate, complete, current or free from error or omission. Content may have been drawn from third-party sources that we do not control and cannot independently verify.

3. Opinion and fair comment. Reviews, rankings and comparative statements on this website are expressions of the honest opinion of the cosmetic scientist model, based on the facts and methodology stated on each page. They are not statements of fact about the quality, safety or efficacy of any product, and are not intended to disparage any brand, manufacturer, retailer or individual. Where a product ranks below others, this reflects the output of the stated methodology and not any allegation that the product is defective, unsafe, mis-sold or unlawful. Any brand that considers a statement inaccurate may contact us.

4. Third-party content and links. This website may contain links to, or reproduce claims from, third-party websites, publications and retailers. We do not endorse, control or accept responsibility for the content, accuracy or availability of any third-party material, nor for any products purchased through third-party links.

5. Nature of the content. All reviews, rankings, scores, figures, category analyses and some images published on Dermatology Review are generated by an artificial intelligence large language model (the “cosmetic scientist/science model”) and represent the output and opinion of that model only. The model is commissioned by an independent third party. Dermatology Review has no control over the model. The model forms its opinion by applying a fixed, published methodology to publicly available information, namely published ingredient lists (INCI), peer-reviewed trial data on individual ingredients, brand-published claims and coded consumer reviews. The content does not represent the views, findings, recommendations or opinions of Dermatology Review, its owners, editors or any named individual. Dermatology Review’s role is limited to making the model’s output publicly available for general information purposes. No product featured on this website has been laboratory-tested, clinically tested, handled or used by the publication or the model. All performance figures, scores, percentages and rankings are modelled projections derived from the stated methodology. They are not measurements, test results, statements of fact or guarantees of how any product will perform on any individual, and no person should rely on them as such.

6. Limitation of liability. To the fullest extent permitted by law, Dermatology Review, its owners, directors, employees, contributors and affiliates exclude all liability for any loss, damage, cost or expense of any kind, whether direct, indirect, consequential or otherwise, arising out of or in connection with the use of this website or reliance on any content published on it, including without limitation any inaccuracy, error or omission, any decision to purchase or use any product, any adverse skin reaction, and any loss of profit, revenue, business or goodwill suffered by any brand, manufacturer or retailer. Nothing in this disclaimer excludes or limits liability that cannot lawfully be excluded or limited.

7. Indemnity. By using this website you agree that you do so at your own risk and that you will not bring any claim for compensation against the publisher or its owners in respect of any matter for which liability has been excluded above.

8. Changes. We may amend this disclaimer at any time. Continued use of the website after any change constitutes acceptance of the amended terms.